Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are covering the company, MarketBeat.com reports. Five ...

Explore Reviva Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RVPH. Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quince Therapeutics (QNCX – Research Report), ...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that are covering the stock, MarketBeat reports.

On November 14 th, 2024, Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported third quarter 2024 financial and operational results and filed its Form 10-Q with the SEC. Reviva provided ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

CUPERTINO, CA – Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH), a clinical-stage pharmaceutical company with a market capitalization of $85.33 million, announced significant changes to its ...

RVPH Reviva Pharmaceuticals Holdings, Inc.

1 Day RVPH 0.70% DJIA 1.39% Russell 2K 1.09% Health Care/Life Sciences -0.37% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CUPERTINO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that ...